Patient stories and testimonials require written HIPAA marketing authorization (45 CFR 164.508(a)(3)) from the patient including the specific uses, expiration, revocation rights, and recipient. M16 Marketing provides authorization forms, captures signatures through compliant workflows, and maintains authorization records aligned to your HIPAA retention policy. Patient stories without proper authorization are never used.

M16 Marketing executes BAAs when our work involves access to PHI. Our analytics stack uses BAA-covered Google Analytics 4 server-side configurations and BAA-covered conversion tracking that does not transmit PHI to non-BAA vendors. The HHS Bulletin on tracking technologies (December 2022, updated 2024) shaped how every M16 healthcare engagement is structured.

For YMYL healthcare content, Google evaluates Experience (real clinical practice), Expertise (board certifications, training), Authoritativeness (institutional affiliations, citations), and Trustworthiness (transparency, accuracy, accountability). M16 builds every YMYL piece with a credentialed physician author byline, citations to peer-reviewed sources, medical review attribution, last-updated dates, and Article and Person schema linking the author to their credentials.

The HHS Office for Civil Rights December 2022 Bulletin (updated 2024) treats certain online tracking technologies as transmitting PHI when they capture identifiable patient interactions. M16 Marketing builds tracking stacks that respect the bulletin: BAA-covered server-side tracking, exclusion of authenticated patient-portal areas from non-BAA tools, and consent-managed tracking on patient-facing pages.

Yes. M16 builds service-line content frameworks that respect each specialty’s distinct medical reviewer, distinct compliance posture (e.g., behavioral health 42 CFR Part 2 vs. oncology vs. orthopedics), and distinct payer mix. Content governance is structured so service lines do not bleed inappropriate claims or messaging across each other.

DTC prescription drug and medical device promotion is governed by FDA OPDP guidance including fair-balance, risk disclosure, and indication-specific standards. M16 Marketing drafts DTC pharma and device content with fair-balance presentation, ISI integration, indication-specific claims, and required submission (Form 2253) preparation aligned to your regulatory affairs team.

M16 builds every healthcare site to WCAG 2.2 AA standards including color contrast, keyboard navigation, screen reader compatibility, form labeling, alt text discipline, and accessible PDF patient resources. We provide annual accessibility audits, remediation logs, and accessibility statements that ADA Title III plaintiffs and counsel will examine if a complaint is filed.

Solo and small specialty practices typically range from $5K to $9K per month. Mid-size multi-physician practices and DTC health brands range from $10K to $20K per month. Multi-location specialty groups and hospital service-line engagements range from $20K to $50K+ per month. Exact scope finalized during the 30-minute audit call.